GlassScriptPhysician profile
Elyssa Drucker
NPI 1629685714
$6,792.21
in general payments reported to CMS, 2019-2025
21 companies · $3,999 in 2025
The $3,999 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $223 · 2023: $1,312 · 2024: $1,258 · 2025: $3,999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,311 · Education: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,311.07 |
| Education | $257.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $891.06 | 2022-2025 | |
| Amgen INC. | $777.94 | 2022-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $586.84 | 2023-2025 | Dupixent |
| Incyte Corporation | $541.27 | 2023-2025 | Opzelura |
| Galderma Laboratories, L.P. | $512.02 | 2025 | Nemluvio |
| Ucb, INC. | $394.90 | 2024-2025 | Bimzelx |
| Janssen Biotech, INC. | $394.30 | 2023-2025 | Tremfya |
| Organon LLC | $371.54 | 2025 | Vtama |
| Genzyme Corporation | $327.57 | 2023-2025 | |
| Leo Pharma INC. | $307.87 | 2024-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $276.77 | 2023-2025 | Ebglyss, Taltz, Olumiant |
| Arcutis Biotherapeutics, INC. | $268.71 | 2024-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $247.68 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $214.51 | 2023-2025 | Sotyktu |
| Pfizer INC. | $150.34 | 2023-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $146.98 | 2022-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $133.97 | 2023-2025 | Jublia, Cabtreo, Siliq |
| Journey Medical Corporation | $128.52 | 2023 | |
| Sun Pharmaceutical Industries INC. | $64.77 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.54 | 2024-2025 | Spevigo |
| Verrica Pharmaceuticals INC. | $15.11 | 2023 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elyssa Drucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.